Dirk Allison: Thanks, John. It seems there’s been a little bit of change in the industry. I think you can see that in that all the providers of hospice over the last couple of quarters have had some struggles as far as growth. There’s a question whether with the pandemic, there was a lot of increased elderly deaths that came through that period of time. And so the question is — some of the indications are, if you look at the government data, the hospice has gone down a little bit over that time frame. So while I don’t believe and I don’t think we as a team believe that’s going to be a long-term change in the hospice environment. We do think there’s some short-term impacts as those — probably those early deaths of elderly patients that would have been on hospice as that kind of moves through when we get back to a more level operation as we consistently have seen in the hospice environment.
So we’re still excited about hospice. I want to make sure you understand that just because it’s not a focus for our M&A at this point in time, that’s largely because we already have about 20% of our revenue in hospice, and we really believe that to get the balance of home health and clinical services set on top of our personal care network is really the strategic way to move forward in the next year or 2.
John Ransom: And so I mean, just a follow-up on that. Do you think length of stay are going to be any different in the future than they used to be? Is there more government scrutiny with and somethings like that? Or again, do you think this some of the struggles maybe your peers have had with shorter length of stay and getting bottleneck referrals? Do you think that’s also temporary notwithstanding the demand issue, structural demand issue on the mortality? Do you see anything with referral networks, length of stay, that kind of thing changing?
Dirk Allison: Well, I think we saw during the pandemic that our length of stay was challenged. That was the industry probably due to what Brad mentioned earlier, and that is we were receiving the hospice patients that were coming on board over the last couple of years seem to have been later in their stage of — in the hospice stage. So their length of stay, once we came on service tended to be shorter than what we had seen historically. The question will be, will we start to see that longer length of stay as the nursing homes, the SNFs get back to after the emergency is declared over. Will it get back to more of the normal approach that when we receive clients straight from a nursing home, the length of stay for those clients tended to be longer.
If you look at the last couple of years, we’ve still received a lot of hospital hospice referrals and their length of stay has not changed a great deal, but those tend to be the shorter length of stay patients. So our belief is we will start to see that change over the next year or 2. But as to what point it really reverts back to a more normalized level, that’s still a question for us.
Operator: The next question comes from Matt Larew with William Blair.
Matt Larew: I wanted to follow up on the comment about home health rates it’s been on the Medicare Advantage side, been a theme for a number of the companies in the space and for years really in terms of getting adequate reimbursement. You referenced your leverage point around Personal Care. But just curious maybe what percentage of your book of business today, you feel on the MA side, you feel like you’re getting adequate reimbursement, what’s unique about the situation and how you’re approaching payers today that might be different than 1 or 3 or 5 years ago?
